Since Jan. 15th, only paying subscribers can access full news articles on our new website. Don’t get left behind. Jan. 31 is the last day to take advantage of our 20 percent off early bird subscription rate. If you have any questions
…Month: January 2021
The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report
…
The U.S. Health Resources and Services Administration (HRSA) is requiring Pharmaceutical Associates, Inc. (PAI), a South Carolina-based generic liquid drug manufacturer, to repay 340B covered entities for charges on its products above the 340B ceiling price discovered
… Illinois-based Eton Pharmaceuticals is making its Alkindi Sprinkle hydrocortisone product available through a sole specialty distributor “to ensure that patients…receive appropriate drug and clinical counseling and to support therapeutic adherence,” the company informed 340B covered entities in
… 
We are in the market for a savvy, seasoned reporter with more than five years of experience in health care journalism to join us on an ongoing basis as an independent contractor.
…
Starting last week, only paying subscribers can access full news articles on our new website. Don’t get left behind. Jan. 31 is the last day to take advantage of our 20 percent off early bird subscription rate. If you have
…
